MARIA LUISA
FERRANDIZ MANGLANO
CATEDRÀTIC/A D'UNIVERSITAT
MIGUEL
PAYA PERIS
CATEDRÁTICO/A DE UNIVERSIDAD
Publications by the researcher in collaboration with MIGUEL PAYA PERIS (25)
2004
-
Histamina y fármacos antihistamínicos. Farmacología de otros mediadores inflamatorios
Velázquez. Farmacología Básica y Clínica (Editorial Médica Panamericana S.A.), pp. 487-500
2003
-
Therapeutic administration of 3,4,5-trimethoxy-4′-fluorochalcone, a selective inhibitor of iNOS expression, attenuates the development of adjuvant-induced arthritis in rats
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 368, Núm. 3, pp. 225-233
-
ttCH, a selective inhibitor of inducible nitric oxide synthase expression with antiarthritic properties
European Journal of Pharmacology, Vol. 465, Núm. 1-2, pp. 183-189
2002
-
Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase
European Journal of Medicinal Chemistry, Vol. 37, Núm. 8, pp. 699-705
2000
-
Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 361, Núm. 1, pp. 98-106
1998
-
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides
Journal of Natural Products, Vol. 61, Núm. 7, pp. 931-935
-
Anti-inflammatory activity in mice of extracts from Mediterranean marine invertebrates
Life Sciences, Vol. 62, Núm. 9
-
Suppression of leukotriene B4 and tumour necrosis factor α release in acute inflammatory responses by novel prenylated hydroquinone derivatives
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 357, Núm. 5, pp. 565-572
1997
-
Variabilin: A dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity
Journal of Pharmacology and Experimental Therapeutics, Vol. 282, Núm. 1, pp. 123-131
1996
-
Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice
Journal of Pharmacy and Pharmacology, Vol. 48, Núm. 9, pp. 975-980
-
Inhibition of inflammatory responses by a series of novel dolabrane derivatives
European Journal of Pharmacology, Vol. 312, Núm. 1, pp. 97-105
-
Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 354, Núm. 5, pp. 677-683
-
Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation
British Journal of Pharmacology, Vol. 117, Núm. 8, pp. 1773-1779
1995
-
A study of the novel anti-inflammatory agent florifenine topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 351, Núm. 3, pp. 298-304
-
Antinociceptive activity of filenadol on inflammatory pain
Life Sciences, Vol. 57, Núm. 14
-
Inhibition of inflammatory responses by epitaondiol and other marine natural products
Life Sciences, Vol. 57, Núm. 2
1994
-
Accelerated communication: Effects of flavonoids on Naja Naja and human recombinant synovial phospholipases A2 and inflammatory responses in mice
Life Sciences, Vol. 54, Núm. 20
-
Avarol and avarone, two new anti-inflammatory agents of marine origin
European Journal of Pharmacology, Vol. 253, Núm. 1-2, pp. 75-82
-
Effects of flavonoids on Naja naja and human recombinant synovial phospholipases A2 and inflammatory responses in mice
Life Sciences, Vol. 54, Núm. 20
-
Hispidulin protection against hepatotoxicity induced by bromobenzene in mice
Life Sciences, Vol. 55, Núm. 8